Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. 549300H9RLRTRTLRUZ73-2023-12-31-en.zipAnnual report 2023

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 19 / 2024
Date of issue: 2024-04-11
Short name of the issuer
KRKA
Subject
Audited consolidated and unconsolidated annual report of company Krka, d. d., Novo mesto for the year 2023
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 134 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the Audited consolidated and unconsolidated annual report for the year 2023.

The report is in the official ESEF format and represents the fulfilment of the obligation to disclose the annual report in accordance with the first paragraph of Article 134 of ZTFI-1 and Commission Delegated Regulation (EU) 2019/815.

The company Krka, d. d., Novo mesto has additionally prepared an unofficial version of the Audited consolidated and unconsolidated annual report for the year 2022 in PDF format that is published on the Company’s website under section Financial reports.


The report will be published on the Company's website (www.krka.biz) from 11 April 2023 onwards, for a period of at least 10 years.
Annexes
File Description
549300H9RLRTRTLRUZ73-2023-12-31-en.zip
549300H9RLRTRTLRUZ73-2023-12-31-en.zip		 Annual report 2023

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-04-11 Jože Colarič President of the Management Board and CEO